411 related articles for article (PubMed ID: 19876027)
1. Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice.
Kim MP; Evans DB; Wang H; Abbruzzese JL; Fleming JB; Gallick GE
Nat Protoc; 2009; 4(11):1670-80. PubMed ID: 19876027
[TBL] [Abstract][Full Text] [Related]
2. Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice.
Ahmed SU; Zair M; Chen K; Iu M; He F; Adeyi O; Cleary SP; Ghanekar A
J Vis Exp; 2013 Sep; (79):e50544. PubMed ID: 24121300
[TBL] [Abstract][Full Text] [Related]
3. Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice.
Kageyama K; Ozaki S; Sato T
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762467
[TBL] [Abstract][Full Text] [Related]
4. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Hellwig D; Menges M; Schneider G; Moellers MO; Romeike BF; Menger MD; Kirsch CM; Samnick S
Nucl Med Biol; 2005 Feb; 32(2):137-45. PubMed ID: 15721759
[TBL] [Abstract][Full Text] [Related]
5. Development of orthotopic pancreatic tumor mouse models.
Qiu W; Su GH
Methods Mol Biol; 2013; 980():215-23. PubMed ID: 23359156
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy.
Erstad DJ; Sojoodi M; Taylor MS; Ghoshal S; Razavi AA; Graham-O'Regan KA; Bardeesy N; Ferrone CR; Lanuti M; Caravan P; Tanabe KK; Fuchs BC
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29903803
[TBL] [Abstract][Full Text] [Related]
7. Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy.
Sharma R; Buitrago S; Pitoniak R; Gibbs JF; Curtin L; Seshadri M; Repasky EA; Hylander BL
Pancreas; 2014 Mar; 43(2):298-305. PubMed ID: 24518511
[TBL] [Abstract][Full Text] [Related]
8. Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
Yao LC; Aryee KE; Cheng M; Kaur P; Keck JG; Brehm MA
Methods Mol Biol; 2019; 1953():241-252. PubMed ID: 30912026
[TBL] [Abstract][Full Text] [Related]
9. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
[TBL] [Abstract][Full Text] [Related]
10. Establishment of human tumor xenografts in immunodeficient mice.
Morton CL; Houghton PJ
Nat Protoc; 2007; 2(2):247-50. PubMed ID: 17406581
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K
J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311
[TBL] [Abstract][Full Text] [Related]
12. Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ mice.
Chen X; Liu B; Li Q; Honorio S; Liu X; Liu C; Multani AS; Calhoun-Davis T; Tang DG
PLoS One; 2013; 8(2):e56903. PubMed ID: 23451107
[TBL] [Abstract][Full Text] [Related]
13. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
15. Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease.
Go KL; Delitto D; Judge SM; Gerber MH; George TJ; Behrns KE; Hughes SJ; Judge AR; Trevino JG
Pancreas; 2017 Jul; 46(6):813-819. PubMed ID: 28609371
[TBL] [Abstract][Full Text] [Related]
16. Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.
Bernstein JM; Brooks SP; Lehman HK; Pope L; Sands A; Shultz LD; Bankert RB
Ann Otol Rhinol Laryngol; 2009 Dec; 118(12):866-75. PubMed ID: 20112521
[TBL] [Abstract][Full Text] [Related]
17. Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograft.
Miers L; DeNardo SJ; Lamborn K; DeNardo GL
Cancer Biother Radiopharm; 2005 Dec; 20(6):614-9. PubMed ID: 16398613
[TBL] [Abstract][Full Text] [Related]
18. Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.
Visonneau S; Cesano A; Torosian MH; Miller EJ; Santoli D
Am J Pathol; 1998 May; 152(5):1299-311. PubMed ID: 9588898
[TBL] [Abstract][Full Text] [Related]
19. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.
Rubio-Manzanares Dorado M; Marín Gómez LM; Aparicio Sánchez D; Pereira Arenas S; Praena-Fernández JM; Borrero Martín JJ; Farfán López F; Gómez Bravo MÁ; Muntané Relat J; Padillo Ruiz J
World J Gastroenterol; 2018 Feb; 24(7):794-809. PubMed ID: 29467550
[TBL] [Abstract][Full Text] [Related]
20. Xenografting and harvesting human ductal pancreatic adenocarcinomas for DNA analysis.
Walter K; Eshleman J; Goggins M
Methods Mol Med; 2005; 103():103-11. PubMed ID: 15542900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
